UNSPSC 51283927: Sulfapyridine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H11N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y5V2N1KE8U, chemically known as sulfanilamide, n(sup 1)-2-pyridyl- but generally known as sulfapyridine, which bears US NIH Compound Identifier 5336. European Medicines Agency schedules Sulfapyridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10724MIG.

UNSPSC 51283927 Sulfapyridine, a Commodity code, shows minimal alignment between its nominal scope and recent state and local procurement activity under this code designation. The recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products — none of which are sulfapyridine, a specific immunosuppressant and anti-inflammatory pharmaceutical ingredient. State and local governments are clearly buying pharmaceutical products, emergency medical supplies, and pharmacy benefit management services through these solicitations, but the code's narrow focus on a single drug compound does not reflect the breadth of what is actually being procured under this UNSPSC tag.

Recent activity spans multiple issuing-body types: a county health department (Seminole County, Florida), a state health and human services agency (Texas HHS Commission), a municipal fire department (City of Tampa), and a multistate cooperative purchasing alliance (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, which includes Oregon). The geographic spread includes Florida, Texas, Minnesota, and Oregon, with the Texas RFI and MMCAP solicitation indicating broader statewide and regional procurement reach. Representative recent opportunities include Seminole County's IFB 60459723LAS (due July 26, 2023, later corrected in materials to reference a 2026 posting) for 1,900 units of naloxone and 800 drug deactivation systems annually; the City of Tampa's IFB 26-P-00145 (due March 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000.00, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; and Minnesota MMCAP's RFP S1070000015802 (due March 26, 2026) for generic pharmaceuticals and OTC products through authorized wholesalers.